Lower expression of MMP3, as a proteolytic enzyme which is well known in the development and spread of inflammatory diseases such as osteoarthritis, was especially observed in treatment group 4 using IHC staining (Fig. 4). This evidence concerns the gene MMP3 and osteoarthritis.